3.74 (-%)
As of Nov 01, 2024
Source:
Leap Therapeutics, Inc. is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | 617 252 4343 |
Industry | manufacturing |
CEO | Douglas E. Onsi |
Website | www.leaptx.com |